These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Involvement of oxygen-sensing pathways in physiologic and pathologic erythropoiesis. Semenza GL Blood; 2009 Sep; 114(10):2015-9. PubMed ID: 19494350 [TBL] [Abstract][Full Text] [Related]
6. Prolyl hydroxylase 2 dependent and Von-Hippel-Lindau independent degradation of Hypoxia-inducible factor 1 and 2 alpha by selenium in clear cell renal cell carcinoma leads to tumor growth inhibition. Chintala S; Najrana T; Toth K; Cao S; Durrani FA; Pili R; Rustum YM BMC Cancer; 2012 Jul; 12():293. PubMed ID: 22804960 [TBL] [Abstract][Full Text] [Related]
7. Erythrocytosis-associated HIF-2alpha mutations demonstrate a critical role for residues C-terminal to the hydroxylacceptor proline. Furlow PW; Percy MJ; Sutherland S; Bierl C; McMullin MF; Master SR; Lappin TR; Lee FS J Biol Chem; 2009 Apr; 284(14):9050-8. PubMed ID: 19208626 [TBL] [Abstract][Full Text] [Related]
8. Disturbance in the HIF-1alpha pathway associated with erythrocytosis: further evidences brought by frameshift and nonsense mutations in the prolyl hydroxylase domain protein 2 (PHD2) gene. Al-Sheikh M; Moradkhani K; Lopez M; Wajcman H; Préhu C Blood Cells Mol Dis; 2008; 40(2):160-5. PubMed ID: 17933562 [TBL] [Abstract][Full Text] [Related]
9. Isolated erythrocytosis: study of 67 patients and identification of three novel germ-line mutations in the prolyl hydroxylase domain protein 2 (PHD2) gene. Albiero E; Ruggeri M; Fortuna S; Finotto S; Bernardi M; Madeo D; Rodeghiero F Haematologica; 2012 Jan; 97(1):123-7. PubMed ID: 21828119 [TBL] [Abstract][Full Text] [Related]
10. Mutations of von Hippel-Lindau tumor-suppressor gene and congenital polycythemia. Pastore Y; Jedlickova K; Guan Y; Liu E; Fahner J; Hasle H; Prchal JF; Prchal JT Am J Hum Genet; 2003 Aug; 73(2):412-9. PubMed ID: 12844285 [TBL] [Abstract][Full Text] [Related]
11. A family with erythrocytosis establishes a role for prolyl hydroxylase domain protein 2 in oxygen homeostasis. Percy MJ; Zhao Q; Flores A; Harrison C; Lappin TR; Maxwell PH; McMullin MF; Lee FS Proc Natl Acad Sci U S A; 2006 Jan; 103(3):654-9. PubMed ID: 16407130 [TBL] [Abstract][Full Text] [Related]
12. The ribosomal chaperone NACA recruits PHD2 to cotranslationally modify HIF-α. Song D; Peng K; Palmer BE; Lee FS EMBO J; 2022 Nov; 41(22):e112059. PubMed ID: 36219563 [TBL] [Abstract][Full Text] [Related]
14. Germ-line PHD1 and PHD2 mutations detected in patients with pheochromocytoma/paraganglioma-polycythemia. Yang C; Zhuang Z; Fliedner SM; Shankavaram U; Sun MG; Bullova P; Zhu R; Elkahloun AG; Kourlas PJ; Merino M; Kebebew E; Pacak K J Mol Med (Berl); 2015 Jan; 93(1):93-104. PubMed ID: 25263965 [TBL] [Abstract][Full Text] [Related]
15. Oxygen sensing by the prolyl-4-hydroxylase PHD2 within the nuclear compartment and the influence of compartmentalisation on HIF-1 signalling. Pientka FK; Hu J; Schindler SG; Brix B; Thiel A; Jöhren O; Fandrey J; Berchner-Pfannschmidt U; Depping R J Cell Sci; 2012 Nov; 125(Pt 21):5168-76. PubMed ID: 22946054 [TBL] [Abstract][Full Text] [Related]
16. The HIF pathway and erythrocytosis. Lee FS; Percy MJ Annu Rev Pathol; 2011; 6():165-92. PubMed ID: 20939709 [TBL] [Abstract][Full Text] [Related]
17. PHD2 mutation and congenital erythrocytosis with paraganglioma. Eltzschig HK; Eckle T; Grenz A N Engl J Med; 2009 Mar; 360(13):1361-2; author reply 1362. PubMed ID: 19321876 [No Abstract] [Full Text] [Related]
18. Isolated Erythrocytosis Associated With 3 Novel Missense Mutations in the Moore JA; Hubbi ME; Wang C; Wang Y; Luo W; Hofmann S; Rambally S J Investig Med High Impact Case Rep; 2020; 8():2324709620947256. PubMed ID: 32755251 [TBL] [Abstract][Full Text] [Related]
19. HIF-1α is a protective factor in conditional PHD2-deficient mice suffering from severe HIF-2α-induced excessive erythropoiesis. Franke K; Kalucka J; Mamlouk S; Singh RP; Muschter A; Weidemann A; Iyengar V; Jahn S; Wieczorek K; Geiger K; Muders M; Sykes AM; Poitz DM; Ripich T; Otto T; Bergmann S; Breier G; Baretton G; Fong GH; Greaves DR; Bornstein S; Chavakis T; Fandrey J; Gassmann M; Wielockx B Blood; 2013 Feb; 121(8):1436-45. PubMed ID: 23264599 [TBL] [Abstract][Full Text] [Related]
20. Src activates HIF-1α not through direct phosphorylation of HIF-1α specific prolyl-4 hydroxylase 2 but through activation of the NADPH oxidase/Rac pathway. Lee HY; Lee T; Lee N; Yang EG; Lee C; Lee J; Moon EY; Ha J; Park H Carcinogenesis; 2011 May; 32(5):703-12. PubMed ID: 21335603 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]